700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
|Isme M de Kleer|
|Erasmus Medical Center, Netherlands|
|Keynote: J Clin Exp Pathol|
|Allergic diseases have their origin in early life when lungs and immune system are still developing. Sensitization to aeroallergens is an important risk factor for asthma in children and influenced by genetic polymorphisms. Ontology of asthma genes indicate the existence of two central themes conferring asthma susceptibility, (i) activation of an innate immune response leading to type-2 immunity (IL33 and IL1RL1, coding for IL-33R and decoy receptor sST2) and (ii) integrity and repair of the airway epithelium (PCDH1 and CDHR3). To understand the susceptibility to allergic asthma of young children, we studied epithelial permeability and innate and type 2 immunity in response to house dust mite (HDM) exposure in neonatal mouse lungs. We found that innate lymphoid type 2 cells (ILC2) and eosinophils spontaneously accumulate in lungs during postnatal alveolarization in an IL-33 dependent manner. HDM exposure further increased IL-33, boosted cytokine production in ILC2, and promoted the migration and Th2 skewing capacity of dendritic cells leading to enhanced sensitization. We found that exposition to high dose HDM resulted in free flow of antigen through the epithelial barrier to the lung draining lymph nodes. This phenomenon was the result of an impaired alveolar barrier due to claudin-18 deficiency expression in alveolar cells. Challenges with high doses of antigen resulted in strong T cell proliferation in lung interstitium and lymph nodes and dendritic cell independent sensitization. We conclude that enhanced neonatal Th2 skewing to inhaled allergens occurs during a phase of postnatal lung remodeling, when the epithelial barrier is not completely closed and the IL-33 axis and spontaneous type 2 immunity drive immunity to allergens.|
Ismé M de Kleer is a Pediatrician and Research Fellow of Pediatric Pulmonology in the Department of Pediatric Pulmonology at Erasmus Medical Center, Rotterdam, Netherlands. She completed her PhD from the Utrecht University in 2004 and Post-doctoral studies at the Flemish Institute for Biotechnology, Ghent University. She is a member of the European Respiratory Society (ERS), Netherlands Respiratory Society (NRS) and Dutch Pediatric Society and has co-authored 27 peer-reviewed articles in international journals.
Email: [email protected]
|PDF | HTML|